Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A human glucagon-like peptide-1 receptor polymorphism results in reduced agonist responsiveness.

Regulatory peptides - 15 Aug 2005

Beinborn Martin, Worrall Christine I, McBride Edward W, Kopin Alan S

Abstract excerpt

Glucagon-like peptide-1 (GLP-1) and its cognate receptor play an important physiological role in maintaining blood glucose homeostasis. A GLP-1 receptor (GLP-1R) polymorphism in which threonine 149 is substituted with a methionine residue has been recently identified in a patient with type 2 diab...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COS Cells
Share to Cyclic AMP
Share to Glucagon-Like Peptide-1 Receptor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucose

Share to Homeostasis

Share to Ligands

Share to Receptors, G-Protein-Coupled

Share to Receptors, Glucagon

Source

Identifiers

PMID: 15975668
DOI: 10.1016/j.regpep.2005.05.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-15975668-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A human glucagon-like peptide-1 receptor polymorphism results in reduced agonist responsiveness.PMID 15975668Read ↗

Differential impact of amino acid substitutions on critical residues of the human glucagon-like peptide-1 receptor involved in peptide activity and small-molecule allostery.Semantic proximity Read ↗

Human GLP1R variants affecting GLP1R cell surface expression contribute to impaired glucose control and increased adipositySemantic proximity Read ↗

Biased agonism and polymorphic variation at the GLP-1 receptor: Implications for the development of personalised therapeuticsSemantic proximity Read ↗

Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.Semantic proximity Read ↗

<i>In vivo</i> functional profiling and structural characterisation of the human <i>Glp1r</i> A316T variantSemantic proximity Read ↗

Minireview: Signal bias, allosterism, and polymorphic variation at the GLP-1R: implications for drug discovery.Semantic proximity Read ↗

Molecular and in vivo phenotyping of missense variants of the human glucagon receptorSemantic proximity Read ↗

A small molecule ligand of the glucagon-like peptide 1 receptor targets its amino-terminal hormone binding domain.Semantic proximity Read ↗

GLP1R (glucagon-like-peptide-1 incretin receptor), diabetes and obesity phenotypes: An in silico approach revealed new pathogenic variants.Semantic proximity Read ↗

Global glucagon-like peptide-2 receptor activation linked to increased obesity risk in the UK Biobank.Semantic proximity Read ↗

Genetic variations in GLP-1R: Impact on diabetes and obesity therapeutics.Semantic proximity Read ↗

Four missense mutations in the ghrelin receptor result in distinct pharmacological abnormalities.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.